-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/head-neck-cancer-update_consumer.pdf
August 01, 2015 - � Radiation therapy: High-energy radiation beams are used to kill
cancer cells in and around the tumor … Radiation therapy uses high-energy radiation beams to kill cancer
cells in and around a tumor. … � It can shrink tumors, reduce some symptoms, and relieve pain. … that hits healthy tissues
around the tumor. … The goal is to:
� Target the tumor with the right amount (dose) of radiation
� Limit the radiation
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_executive.pdf
October 01, 2015 - These
include the stage of the cancer, tumor grade (higher grade
tumors are more likely to recur and … progress), whether the
tumor is an initial tumor or a recurrence, number and size
of tumors, and patient … tumors (SOE: high) … versus smaller
tumors (SOE: low) … 1 cm or >2 cm) vs. smaller tumors.
-
effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-apbi-breast-cancer.pdf
August 01, 2022 - patients with early stage breast cancer reduces tumor
recurrence and increases survival.4 According … cancer stage, tumor size,
tumor margin status,
estrogen receptor status, etc. … Comparison of Treatment Costs for Breast Cancer, by Tumor
Stage and Type of Service. … syndrome"/ or inflammatory breast neoplasms/
or triple negative breast neoplasms/ or unilateral breast … neoplasms/ (295124)
2 (breast adj5 (cancer* or carcinoma* or invasive or malignan* or noninvasive or
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-test_executive.pdf
April 01, 2013 - leading cause of cancer deaths in men
in the United States.1,2 Most patients
have slow-growing tumors … lifetime risk of dying from the disease
is only 3 percent.1,3,5 However, some
patients have aggressive tumors … effectiveness of using PCA3 testing alone, or
in combination with the standard prognostic workup
(e.g., tumor … PCA3 score before radical
prostatectomy predicts extracapsular extension and tumor volume. … PCA3 molecular
urine assay correlates with prostate cancer tumor volume:
implication in selecting candidates
-
effectivehealthcare.ahrq.gov/health-topics/cancer?page=1
-
effectivehealthcare.ahrq.gov/products/liver-cancer/research-protocol/
-
effectivehealthcare.ahrq.gov/products/liver-cancer-therapy/research-protocol
March 20, 2012 - Unlike most solid tumors, the future incidence of and mortality rate due to HCC are projected to increase … using the following string of search terms:
"Carcinoma, Hepatocellular"[Mesh] OR (hepatocellular AND (neoplasm … * OR cancer OR cancers OR carcinoma)) AND Unresectable OR nonresectable OR inoperable OR irresectable … comparative studies, and case series by using the following string of search terms:
hepatocellular AND (neoplasm … * OR cancer OR cancers OR carcinoma) AND (unresectable OR nonresectable OR inoperable OR irresectable
-
effectivehealthcare.ahrq.gov/products/breast-cancer-imaging/research-protocol
December 17, 2013 - stage
Comparator
Comparison of multiple imaging modalities
No comparator
None
Outcomes
Tumor … of Items Found
1
exp Diagnostic Imaging
1737346
2
exp Breast Neoplasms/dh, dt, pc, rt, su, … Diet Therapy, Drug Therapy, Prevention & Control, Radiotherapy, Surgery, Therapy]
101054
3
exp Neoplasm … survival analysis/
190795
11
6 or 7
1163519
12
1 and 2 and 5 and 11
632
13
exp *Breast Neoplasms … Type(s) of imaging described
Comparator
Type(s) of comparators, if any
Outcomes measured
Tumor
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer_surveillance.pdf
August 01, 2012 - oral or paranasal or para-nasal or nasal or sinus or salivary or parotid).ti,ab. (1428510)
3 (neoplasm … or neoplasms or tumor or tumors or tumour or tumours or cancer or cancers or
adenocarcinoma or carcinoma … oral or paranasal or para-nasal or nasal or sinus or salivary or parotid).ti,ab. (1428510)
39 (neoplasm … or neoplasms or tumor or tumors or tumour or tumours or cancer or cancers or
adenocarcinoma or carcinoma … or neoplasms or tumor or tumors or tumour or tumours or cancer or cancers or adenocarcinoma or carcinoma
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/radiation-therapy-brain-metases-protocol.pdf
October 10, 2019 - studies have
shown that prognosis can vary substantially.5-8 Brain metastases occur with a variety of
cancers … While treatment for brain metastases from other primary cancers
and in pediatric patients is equally … Epidemiology of metastatic brain tumors. … Effect of tumor subtype on survival and the
graded prognostic assessment for patients with breast cancer … OR cancer* OR neoplasm* OR
carcinoma* OR metastasectomy)))
AND
(MH "Radiosurgery") OR TI(radiation
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests-update_executive.pdf
February 01, 2012 - is one of the most
common malignancies of women, with
approximately 200,000 new cases
diagnosed … every year in the United
States.1 Some breast cancers are identified
by physical examination (either … Women with readily treatable early-stage
cancers who mistakenly get triaged into
“return to normal … Prospective sonographic study of
3093 breast tumors. J Ultrasound Med. 1999 May;18(5):363-70. … D galactose-based
signal-enhanced color Doppler sonography of breast tumors and
tumorlike lesions.
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/comparative-effectiveness-of-ultrasound-us-conventional-computed-tomography-ct-multidetector-computed-tomography-mdct-magnetic-resonance-imaging-mri-fludeoxyglucose-positron-emission-tomography-fdg-pet-or-fdg-petct-for-the-pr
December 27, 2011 - Population at high risk for pancreatic cancer, and patients diagnosed with pancreatic cancer who require … Pancreatic cancer is one of the most aggressive malignant tumor types. … With less than 5% 5-year survival rate, pancreatic cancer is one of the deadliest cancers. … by CT (MDCT); PET/CT; endoscopic ultrasound, CT and MR for premalignant or non-invasive intraductal neoplasms … The risk of pancreatic cancer affects the general US population, men and women.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-surveillance_executive.pdf
December 01, 2011 - The
cancer is usually localized, and most tumors
have low histological grades and low Gleason
scores. … low-risk tumors. … cancer patients with other primary tumors were
consistently less likely to die of prostate cancer compared … Tumor grade
Three studies reported information on prostate cancer
mortality stratified by tumor grade … The two studies
reporting on T1/T2 tumors both demonstrated a decrease of
T1a/T1b tumors and T2a tumors
-
effectivehealthcare.ahrq.gov/products/cancer-ovarian-contraceptives/research-protocol
February 15, 2012 - typically presents at a much later stage than other common cancers. 1 This in turn has led to intense … identified at Stage I may represent a subgroup of less aggressive tumors rather than a necessary first … step in the development of all tumors. … If this is the case, screening, which is more likely to identify slower growing tumors, may have only … of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/dcis-prognostic-tests_research.pdf
August 22, 2012 - and higher grade
tumors. … The percentage of women
with ER+ tumors was similar for the DCIS and invasive
cancer groups. … Tumors larger
than 1 cm and high-grade tumors were associated with
higher rates of HER2 testing except … Treatment targeted to ER+ tumors is very
effective for women with invasive cancers
and ER testing is … HER2 testing to manage patients
with breast cancer or other solid tumors.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/dcis-mri-utilization_research.pdf
August 01, 2012 - The typical treatment for both DCIS and early invasive breast
cancer is surgical removal of the tumor … Rural refers to counties with
fewer than 2,500 people.15
Tumor size: We defined tumor size using the … Use was higher for women
with larger or higher grade tumors. … bilateral breast cancers. … In general, women with higher risk DCIS
(larger tumor size, higher grade disease, or
ER-negative tumors
-
effectivehealthcare.ahrq.gov/products/accelerated-partial-breast-irradiation/key-questions
April 14, 2021 - subclinical disease following the surgical removal of tumors. 3
Radiation therapy administered in … patients with early stage breast cancer reduces tumor recurrence and increases survival. 4 , 5 Variations … part of PBI, radiation is delivered to tissue only immediately adjacent to the site of the removed tumor … Consider patient characteristics such as age, breast cancer type, breast cancer stage, tumor size, tumor … WBI
Outcomes
Breast cancer recurrence, survival, cancer-free survival, quality of life.
-
effectivehealthcare.ahrq.gov/products/cancer-decision-support-tools/research-protocol
November 12, 2013 - Health care consumers with a very strong predisposition to malignancy (e.g., high cancer risk genetic … modified to the correct terminology for CINAHL, PsycINFO, EMBASE, and any other databases searched:
("Neoplasms … "[Mesh] OR cancer OR cancers OR neoplasm* OR malignan* OR premalignan* OR precancerous OR hypertrophy … before and after”[tiab] or interrupted time*[tiab] or time serie*[tiab] or intervention*[tiab]))) AND (("Neoplasms … "[Mesh] OR cancer OR cancers OR neoplasm* OR malignan* OR premalignan* OR precancerous))
Filters:Publication
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy-executive.pdf
December 01, 2009 - Layout 1
Background
Breast cancer is the second most common
malignancy of women, with over 180,000 … However, it is generally acknowledged
that early diagnosis and treatment of breast tumors
leads to improved … The
theoretical cohort of women includes 300 women with
malignant tumors and 700 women with benign lesions … Summary of key accuracy findings (Key Question 1)
Number of Number of
Number of malignancies invasive … missed Risk of expected per cancers
cancers malignancy 1,000 biopsy expected per Strength of
expected
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-update_clinician.pdf
January 01, 2016 - includes tumors confined
to the prostate (T1–T2) and tumors with extracapsular
extension but without … be influenced
by factors such as patient age and health at the time of
diagnosis, life expectancy, tumor … therapy (e.g., androgen deprivation therapy [ADT])
Interstitial brachytherapy: a strategy whereby tumor … –� Recommended treatment options based on the patient’s
age, health status, life expectancy, and tumor … stage
–� The potential for tumor eradication with treatment
–� Available evidence for the efficacy and